Vaccine Therapy and GM-CSF in Treating Patients With Progressive Non-Hodgkin's Lymphoma

NCT00104819 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

238

Enrollment

INDUSTRY

Sponsor class

Stopped Withdrawn as company has shut down and filed for bankruptcy

Conditions

Lymphoma

Interventions

BIOLOGICAL: autologous immunoglobulin idiotype-KLH conjugate vaccine
BIOLOGICAL: sargramostim

Sponsor

Favrille

Collaborators

[object Object]